Phase I/II Study of Monoclonal Antibody Therapy and Interleukin-2 in the Treatment of Leukemia and Lymphoma

RATIONALE: Monoclonal antibodies can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. Interleukin-2 may stimulate a person’s white blood cells to kill leukemia or lymphoma cells. Comb...